英诺欧奇生物医药

Inno-Ouchy Biopharmaceuticals is a Suzhou-based biotechnology company dedicated to the discovery and development of innovative non-opioid analgesics. Founded in 2021, the company focuses on targeting specific ion channels, particularly Nav1.7 and Nav1.8, to address various types of chronic and acute pain. By leveraging its proprietary ion channel drug discovery platform, Inno-Ouchy aims to create highly selective small molecule inhibitors with improved safety profiles compared to existing treatments. The company's lead programs are currently in the IND-enabling and early clinical stages, targeting indications such as postoperative and neuropathic pain. Inno-Ouchy is backed by leading Chinese investors, including Oriza Seed and BioBAY.